The amount of € 7,500 is awarded to a radiotherapy professional for research in the field of radiobiology, radiation physics, clinical radiotherapy or radiation technology, during the ESTRO Annual Congress.
In uneven years, the amount of € 2,500 is awarded to:
Recipients
2020 ESTRO Online Congress
S. Spampinato (IT) - Risk factors for urinary incontinence in locally advanced cervix cancer: an EMBRACE analysis
2018 ESTRO 37 Barcelona
A. Berlin (CA) - Subpathologies and genomic classifier for individualized post-prostatectomy radiotherapy
2017 ESTRO 36 Vienna
C. Locke (US) - Trajectory Optimization in Radiotherapy Using Sectioning (TORUS)
2016 ESTRO 35 Turin
K. Farr (DK) - Perfusion SPECT can quantify radiation-induced changes in the lung after IMRT for NSCLC
2015 3rd ESTRO Forum Barcelona
S. Bisht (IN) - Quantification of coronary artery motion: Analysis from ECG gated radiotherapy planning scan
2014 ESTRO 33 Vienna
B. Hoeben (NL) - PET imaging for characterization of head and neck tumours
2013 2nd ESTRO Forum Geneva
S. Thörnqvist (DK) - Motion simulations with a statistical deformation model to evaluate PTV margins in locally advanced prostate cancer
2012 ESTRO 31 Barcelona
P. Georg (AT) - Reporting of late rectal and urinary bladder side effects after MRI guided adaptive brachytherapy of cervix cancer
2011 ESTRO Anniversary Conference London
A. Houweling (NL) - Understanding xerostomia: The role of MRI to visualize early radiation-induced changes in salivary glands
G. Kragl (AT) - Radiotherapy with unflattened photon beams: dosimetric accuracy of treatment planning systems
2010 ESTRO 29 Barcelona
E.Troost (NL) - Validation of PET for non-invasive characterization of head and neck tumours
2009 10th Biennial Meeting on Physics and Radiation Technology for Clinical Radiotherapy Maastricht
E. Sterpin (BE) - A New Method for Output Factors Measurements/MC Computations for Stereotactic and Dynamic Jaws Tomotherapy
2008 ESTRO 27 Göteborg
P. Martinive (BE) - Consequences of Intermittent Hypoxia on the Radio - resistance of the Vascular and the Tumor cell compartments
A. Knopf (USA) - Quantitative assessment of the reproducibility and the consistency of proton beam range verification with PET/CT.
2007 9th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy Barcelona
D. Thorwarth (DE) - Biologically adapted radiotherapy on the basis of hypoxia imaging with FMISO PET
ECCO14 / ESTRO 26 Barcelona
D. Zips (DE) - Experimental evaluation of anti-angiogenic strategies to improve outcome after fractionated radiotherapy
2006 ESTRO 25 Leipzig
J. Jaal (DE/EST) - Pathogenesis and modification of radiation-induced urinary bladder dysfunction
2005 8th Biennial ESTRO Meeting on Physics and Radiation Technology for Clinical Radiotherapy Lisbon
JJ Sonke, Amsterdam, The Netherlands - Kilo-Voltage Cone-beam CT for Image-guided radiation Therapy
ECCO13 / ESTRO 24 Paris
D. Vordermark, Halle, Germany - Molecular markers of tumour hypoxia
L.R. van Veelen, Vlissingen, The Netherlands - Repair of DNA double-strand breaks in radiation induced cellular damage
2004 ESTRO 23 Amsterdam
J.F. Daisne, Brussels, Belgium - Multimodality imaging (Computed Tomography, Magnetic Resonance Imaging and Positron Emission Tomography) for radiotherapy planning of pharyngo-laryngeal tumours
2003 Copenhagen Geneva
Clinical Research Award: Y. Lievens, University Hospital Gasthuisberg, Leuven, Belgium - Cost and economic evaluation of radiotherapy. Activity-based costing and modelling techniques
Biology Research Award: C. Pedersen, Dresden, Germany - Possible impact of the impairment of recovery from sub-lethal repair on repopulation in human squamous cell carcinoma FaDu during fractionated radiotherapy
Physics Research Award: C. Thieke, Heidelberg, Germany - Multi-criteria optimisation in inverse radiotherapy planning
2002 Prague
L.P. Muren, Bergen, Norway - A contribution to improved radiotherapy for muscle invading urinary bladder cancer
S. Nuyts, U.H. Gasthuisberg, Leuven, Belgium - Clostridium bacteria and radiotherapy: a way to target hypoxic tumours?
2001 Lisbon - Seville
Clinical Research Award: C.M. Nutting, Royal Marsden HNS Trust, Sutton, UK - Intensity-modulated radiation therapy (IMRT) for tumours of the head and neck, pelvis and thorax: pre-clinical evaluation and implementation
Biology Research Award: A. Dasu, Umea University, Sweden - Modelling the impact of two forms of hypoxia on novel radiotherapy approaches
Physics Research Award: M. Alber, Universitätsklinikum Tübingen, Germany - Enhanced biological planning and expedited delivery of IMRT
2000 Istanbul
Clinical Research Award: J. Bussink, Nijmegen, The Netherlands - Impact of hypoxia modification on the tumour microenvironment
1999 Vienna
Clinical Research Award: 1st Prize I. Hojris, Danish Cancer Society, Aarhus, Denmark - Late morbidity following systemic treatment with or without post-mastectomy irradiation in patients with breast cancer
2nd Prize: C. Vrieling, The Netherlands Cancer Institute, Amsterdam, NL - The cosmetic results, and the influence of age on local control in the EORTC "boost versus no boost" trial
Physics Research Award (Göttingen): I. Ferreira, Institut Gustave Roussy, Villejuif, France - Determination of the dose perturbations produced in thermoluminescent dosimeters and ionisation chambers irradiated with high energy photon beams
1998 Edinburgh
Clinical Research Award: K. Skladowski, Maria Sklodowska-Curie Memorial Institute, Gliwice, Poland - Continuous accelerated irradiation in head & neck cancer
Biology Research Award: A.E. Kiltie, Cookridge Hospital, Leeds, UK - A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients
Physics Research Award: M. Karlsson, Umea University, Umea, Sweden - Advanced electron beams for external radiation therapy
1997 Hamburg
Clinical Research Award: M. Nordsmark, Danish Cancer Society, Aarhus, Denmark - Experimental and clinical studies of polarographic oxygen electrode measurements and 31P magnetic resonance spectroscopy as predictive assays in radiation therapy
Biology Research Award: M. Verheij, Netherlands Cancer Institute, Amsterdam, NL - The role of the sphingomyelin signal transduction pathway in radiation-induced apoptosis
Physics Research Award: D. Corletto, Hospital San Raffaele, Milano, Italy - Dose calculation and dosimetry tests for clinical implementation of 1D tissue-deficit compensation by a single dynamic absorber
1996 Vienna
Clinical Research Award: K. Haustermans, U.H. Gasthuisberg, Leuven, Belgium - The applicability of Tpot as a predictive test for treatment outcome
Biology Research Award: B. Dubray, Institut Curie, Paris, France - Estimation of radiobiological parameters for rodent rectum, human lung and on heterogeneous patient population
Physics Research Award: A. Tilikidis, Karolinska Hospital, Stockholm, Sweden - Microdosimetric description of beam quality and biological effectiveness in radiation therapy
1995 Paris
Clinical/Radiobiological Research Award: A. Safwat, Cairo University, Faculty of Medicine, Cairo, Egypt - The clinical, physical and radiobiological aspects of total body irradiation
Physics Research Award: M. Essers, Netherlands Cancer Institute, Amsterdam, NL - CT-based dose calculations and in vivo dosimetry for lung cancer treatment
1994 Granada
Clinical Research Award: L.J. Boersma, Antoni van Leeuwenhoekhuis, Amsterdam, NL - Radiation damage of the lung as a function of dose and volume: a clinical study
Biology Research Award: M. Smeets, Antoni van Leeuwenhoekhuis, Amsterdam, NL - The effect of radiation on G2 blocks, cyclin B expression and CDC2 expression in human squamous carcinoma cell lines with different radiosensitivities
Physics Research Award: A. Neal, The Royal Marsden Hospital, Sutton, Surrey, UK - CT planning for tangential breast irradiation - II: correlation of breast dose inhomogeneity with breast size using dose-volume histograms
1993 Jerusalem
1st Prize: P. Lambin, U.H. St. Rafaël, Leuven, Belgium - Low dose radiation response of human tumour cell lines of different intrinsic radiosensitivity
2nd Prize: I. Bravo, Institute Portugues de Oncologia, Porto, Portugal - Response of carcinoma of the uterine cervix to radiotherapy: practical value of cell cycle analysis and proliferation index in the identification of prognostic different subgroups
1992 Malmö
1st Prize: G. Leunens, U.H. St. Rafaël, Leuven, Belgium - Monitoring of quality of the treatment process in a radiotherapy department by in vivo dosimetry
2nd Prize: S.J. Whitaker, The Royal Marsden Hospital, London, UK - The quantification of ionizing radiation induced DNA double-strand breaks in polymine depleted cells
3rd Prize: N.G. Burnet, The Institute of Cancer Research, Sutton, Surrey, UK - The relationship between cellular radiation sensitivity and tissue response to radiotherapy may provide the basis for individualising radiotherapy schedules.
1991 Florence
1st Prize: M.E.A. O'Connell, The Royal Marsden Hospital, Sutton, Surrey, UK - Treatment outcome and radio-iodine dose-response in differentiated thyroid carcinoma
2nd Prize: V. Grégoire, M.D. Anderson Cancer Center, Houston, Texas, USA - Therapeutic gain by boron neutron capture therapy (BNCT): an experimental study
3rd Prize: M.D. Leslie, Mount Vernon Hospital, Northwood, Middlesex, UK - Salivary gland function and radiotherapy: the reduction of late damage by altered fractionation
1990 Montecatini
1st Prize: G. Stüben, Universitätsklinikum, Essen, Germany - Comparison of low dose-rate and fractionated high-dose rate irradiations in identical overall treatment time: role of capacity and kinetics of repair
2nd Prize: S. Powell, Institute of Cancer Research, Sutton, Surrey, UK - Clonal variation of DNA repair in a human glioma cell line
3rd Prize: (ex aequo) R. van der Maazen, Institute of Radiotherapy, Nijmegen, NL - Radiosensitivity of glial progenitor cells of the perinatal and adult rat optic nerve studied by an in vitro clonogenic assay
1989 London
1st Prize: N.P. Rowell, The Royal Marsden Hospital, Sutton, Surrey, UK - The effects of single dose oral hydralazine on blood flow through human lung tumours
2nd Prize: L.G.J. Letschert, The Netherlands Cancer Institute, Amsterdam, NL - Dose-volume correlation in radiation-related late small-bowel complications, a clinical study
3rd Prize: D. De Ruysscher, U.H. St. Rafaël, Leuven, Belgium - Mechanisms involved in the differential recovery of CD4 and CD8 T-lymphocytes after local irradiation
1988 The Hague
1st Prize: M. van Herk, The Netherlands Cancer Institute, Amsterdam, NL - A matrix ionisation chamber imaging device for on-line patient set-up verification during radiotherapy
2nd Prize: E. Van Limbergen, U.H. St. Rafaël, Leuven, Belgium - Breast conserving treatment for mammary cancer. Assessment of local control and quantitative measurements of late fibrosis: influence or radiation dose & fractionation schedules
1987 Lisbon
1st Prize: G. Duchesne, The Royal Marsden Hospital, Sutton, Surrey, UK - The biology of lung cancer: experimental observations and a review of current concepts
2nd Prize: P. Scalliet, U.H. St. Rafaël, Leuven, Belgium - Investigations of repair characteristics in early and late reacting tissues. Comparison of fractionated and low dose rate experiments
3rd Prize: C. Grau, University Hospital, Aarhus, Denmark - Effects of cancer chemotherapy on the hypoxic fraction in a solid tumour measured using a local tumour control assay
1985 Stockholm
1st Prize: P.M. Price & P.J. Hoskin, Royal Marsden Hospital, Sutton Surrey, UK - Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bone metastases.
2nd Prize: M.S. Zaghoul, National Cancer Institute, Cairo, Egypt - Normalization of multiple fractions per day and conventional daily fractionation treatment of painful bone metastases
3rd Prize: L. Vanuytsel, U.H. St. Rafaël, Leuven , Belgium - The effect of the combination of bleomycin and irradiation on the mouse lip mucosa